sj-docx-1-ict-10.1177_15347354231198090 – Supplemental material for Comparison of Plasma Metabolites From Patients With Non-Small Cell Lung Cancer by Erlotinib Treatment and Skin Rash

Supplemental material, sj-docx-1-ict-10.1177_15347354231198090 for Comparison of Plasma Metabolites From Patients With Non-Small Cell Lung Cancer by Erlotinib Treatment and Skin Rash by Won Kil Lee, Jisoo Myong, Eunbin Kwag, Younmin Shin, Ji Woong Son, Byong Chul Yoo, Byoung-Soo Kim, Hwa-Seung Yoo and Jeong June Choi in Integrative Cancer Therapies</p

Baseline Characteristics of Participants (n = 185).

<p>Baseline Characteristics of Participants (n = 185).</p

Attitudes towards E-Cigarette Regulation among Participants.

<p>Attitudes towards E-Cigarette Regulation among Participants.</p

Counseling Preparedness on E-Cigarette Use among Participants.

<p>Counseling Preparedness on E-Cigarette Use among Participants.</p

Current practice of lung cancer screening recommendation among lung cancer specialist physicians.

<p>Current practice of lung cancer screening recommendation among lung cancer specialist physicians.</p

Opinions on the public funding of national lung cancer screening program among lung cancer specialist physicians.

<p>Opinions on the public funding of national lung cancer screening program among lung cancer specialist physicians.</p

Characteristics of the participants (N = 183).

<p>Characteristics of the participants (N = 183).</p

Attitudes towards national lung cancer screening program (NLCSP) among lung cancer specialist physicians.

<p>Attitudes towards national lung cancer screening program (NLCSP) among lung cancer specialist physicians.</p

Attitudes toward lung cancer screening by low-dose computed tomography among lung cancer specialist physicians.

<p>Attitudes toward lung cancer screening by low-dose computed tomography among lung cancer specialist physicians.</p

Physician-perceived reasons for refusal of lung cancer screening among people who are indicated.

<p>Physician-perceived reasons for refusal of lung cancer screening among people who are indicated.</p